http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 24 Jul 2026 07:24:19 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Analyst+PT+Change/West+Pharmaceutical+%28WST%29+PT+Raised+to+%24420+at+Deutsche+Bank/26810621.html Deutsche Bank analyst Justin Bowers raised the price target on West Pharmaceutical (NYSE: WST) to $420.00 (from $405.00) while maintaining a Buy rating. http://www.streetinsider.com/Analyst+PT+Change/West+Pharmaceutical+%28WST%29+PT+Raised+to+%24420+at+Deutsche+Bank/26810621.html Fri, 24 Jul 2026 07:24:19 -0400 WST http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++WEST+PHARMACEUTICAL+SERV++For%3A+Jun+30/26808322.html si-local-file:///var/storage/secattach/20260723/26808322.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++WEST+PHARMACEUTICAL+SERV++For%3A+Jun+30/26808322.html Thu, 23 Jul 2026 16:16:00 -0400 O.00001036 WST http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++WEST+PHARMACEUTICAL+SERV++For%3A+Jun+30/26808322.html si-local-file:///var/storage/secattach/20260723/26808322.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++WEST+PHARMACEUTICAL+SERV++For%3A+Jun+30/26808322.html Thu, 23 Jul 2026 16:16:00 -0400 O.00001036 WST http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++WEST+PHARMACEUTICAL+SERV++For%3A+Jul+23/26804469.html si-local-file:///var/storage/secattach/20260723/26804469.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++WEST+PHARMACEUTICAL+SERV++For%3A+Jul+23/26804469.html Thu, 23 Jul 2026 07:15:00 -0400 O.00001036 WST http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++WEST+PHARMACEUTICAL+SERV++For%3A+Jul+23/26804469.html si-local-file:///var/storage/secattach/20260723/26804469.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++WEST+PHARMACEUTICAL+SERV++For%3A+Jul+23/26804469.html Thu, 23 Jul 2026 07:15:00 -0400 O.00001036 WST http://www.streetinsider.com/Earnings/West+Pharma+%28WST%29+Tops+Q2+EPS+by+29c+%3B+Offers+Guidance/26803940.html <p>West Pharma (NYSE: WST) reported Q2 EPS of $2.37, $0.29 better than the analyst estimate of $2.08. Revenue for the quarter came in at $872.3 million versus the consensus estimate of $839.75 million.</p><p><strong>GUIDANCE:</strong></p><p>West Pharma sees FY2026 EPS of $8.85-$9.05, versus the consensus of $8.62. West Pharma sees FY2026 revenue of $3.34-3.38 billion, versus the consensus of $3.33 billion.</p><p>West Pharma sees Q3 2026 EPS of $2.14-$2.24, versus the consensus of $2.12. West Pharma sees Q3 2026 revenue of $820-835 million, versus the consensus of $814.7 million.</p><p>For earnings history and earnings-related data on West Pharma (WST) <a href="http://www.streetinsider.com/ec_earnings.php?q=WST">click here</a>.</p> http://www.streetinsider.com/Earnings/West+Pharma+%28WST%29+Tops+Q2+EPS+by+29c+%3B+Offers+Guidance/26803940.html Thu, 23 Jul 2026 06:07:20 -0400 WST http://www.streetinsider.com/Guidance/West+Pharma+%28WST%29+Tops+Q2+EPS+by+29c+%3B+Offers+Guidance/26803940.html <p>West Pharma (NYSE: WST) reported Q2 EPS of $2.37, $0.29 better than the analyst estimate of $2.08. Revenue for the quarter came in at $872.3 million versus the consensus estimate of $839.75 million.</p><p><strong>GUIDANCE:</strong></p><p>West Pharma sees FY2026 EPS of $8.85-$9.05, versus the consensus of $8.62. West Pharma sees FY2026 revenue of $3.34-3.38 billion, versus the consensus of $3.33 billion.</p><p>West Pharma sees Q3 2026 EPS of $2.14-$2.24, versus the consensus of $2.12. West Pharma sees Q3 2026 revenue of $820-835 million, versus the consensus of $814.7 million.</p><p>For earnings history and earnings-related data on West Pharma (WST) <a href="http://www.streetinsider.com/ec_earnings.php?q=WST">click here</a>.</p> http://www.streetinsider.com/Guidance/West+Pharma+%28WST%29+Tops+Q2+EPS+by+29c+%3B+Offers+Guidance/26803940.html Thu, 23 Jul 2026 06:07:20 -0400 WST http://www.streetinsider.com/Press+Releases/West+Reports+Second-Quarter+2026+Results/26803582.html <div class="xn-content"> <p class="prntac"><i>Raising Full-Year <person>Net Sales</person> and EPS guidance</i></p><p><span class="legendSpanClass"><location value="LU/us.pa.exton" idsrc="xmltag.org" >EXTON, Pa.</location></span>, <span class="legendSpanClass"><chron>July 23, 2026</chron></span> /PRNewswire/ -- <span value="NYSE:WST" idsrc="xmltag.org" >West Pharmaceutical Services, Inc.</span> (NYSE: WST), a leading provider of innovative, high-quality injectable solutions and services, today announced its financial results for the second quarter of 2026.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> <img src="https://mmx.prnewswire.com/media/MS513349/west-pharma-large-Logo.jpg?id=OA2780622" title="" alt="" /> http://www.streetinsider.com/Press+Releases/West+Reports+Second-Quarter+2026+Results/26803582.html Thu, 23 Jul 2026 06:00:00 -0400 A.13029261 O.00001036 O.03056012 WST http://www.streetinsider.com/Press+Releases/West+Reports+Second-Quarter+2026+Results/26803582.html <div class="xn-content"> <p class="prntac"><i>Raising Full-Year <person>Net Sales</person> and EPS guidance</i></p><p><span class="legendSpanClass"><location value="LU/us.pa.exton" idsrc="xmltag.org" >EXTON, Pa.</location></span>, <span class="legendSpanClass"><chron>July 23, 2026</chron></span> /PRNewswire/ -- <span value="NYSE:WST" idsrc="xmltag.org" >West Pharmaceutical Services, Inc.</span> (NYSE: WST), a leading provider of innovative, high-quality injectable solutions and services, today announced its financial results for the second quarter of 2026.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> <img src="https://mmx.prnewswire.com/media/MS513349/west-pharma-large-Logo.jpg?id=OA2780622" title="" alt="" /> http://www.streetinsider.com/Press+Releases/West+Reports+Second-Quarter+2026+Results/26803582.html Thu, 23 Jul 2026 06:00:00 -0400 A.13029261 O.00001036 O.03056012 WST http://www.streetinsider.com/Press+Releases/West+Reports+Second-Quarter+2026+Results/26803582.html <div class="xn-content"> <p class="prntac"><i>Raising Full-Year <person>Net Sales</person> and EPS guidance</i></p><p><span class="legendSpanClass"><location value="LU/us.pa.exton" idsrc="xmltag.org" >EXTON, Pa.</location></span>, <span class="legendSpanClass"><chron>July 23, 2026</chron></span> /PRNewswire/ -- <span value="NYSE:WST" idsrc="xmltag.org" >West Pharmaceutical Services, Inc.</span> (NYSE: WST), a leading provider of innovative, high-quality injectable solutions and services, today announced its financial results for the second quarter of 2026.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> <img src="https://mmx.prnewswire.com/media/MS513349/west-pharma-large-Logo.jpg?id=OA2780622" title="" alt="" /> http://www.streetinsider.com/Press+Releases/West+Reports+Second-Quarter+2026+Results/26803582.html Thu, 23 Jul 2026 06:00:00 -0400 A.13029261 O.00001036 O.03056012 WST http://www.streetinsider.com/Press+Releases/West+Reports+Second-Quarter+2026+Results/26803582.html <div class="xn-content"> <p class="prntac"><i>Raising Full-Year <person>Net Sales</person> and EPS guidance</i></p><p><span class="legendSpanClass"><location value="LU/us.pa.exton" idsrc="xmltag.org" >EXTON, Pa.</location></span>, <span class="legendSpanClass"><chron>July 23, 2026</chron></span> /PRNewswire/ -- <span value="NYSE:WST" idsrc="xmltag.org" >West Pharmaceutical Services, Inc.</span> (NYSE: WST), a leading provider of innovative, high-quality injectable solutions and services, today announced its financial results for the second quarter of 2026.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> <img src="https://mmx.prnewswire.com/media/MS513349/west-pharma-large-Logo.jpg?id=OA2780622" title="" alt="" /> http://www.streetinsider.com/Press+Releases/West+Reports+Second-Quarter+2026+Results/26803582.html Thu, 23 Jul 2026 06:00:00 -0400 A.13029261 O.00001036 O.03056012 WST http://www.streetinsider.com/PRNewswire/West+Reports+Second-Quarter+2026+Results/26803582.html <div class="xn-content"> <p class="prntac"><i>Raising Full-Year <person>Net Sales</person> and EPS guidance</i></p><p><span class="legendSpanClass"><location value="LU/us.pa.exton" idsrc="xmltag.org" >EXTON, Pa.</location></span>, <span class="legendSpanClass"><chron>July 23, 2026</chron></span> /PRNewswire/ -- <span value="NYSE:WST" idsrc="xmltag.org" >West Pharmaceutical Services, Inc.</span> (NYSE: WST), a leading provider of innovative, high-quality injectable solutions and services, today announced its financial results for the second quarter of 2026.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> <img src="https://mmx.prnewswire.com/media/MS513349/west-pharma-large-Logo.jpg?id=OA2780622" title="" alt="" /> http://www.streetinsider.com/PRNewswire/West+Reports+Second-Quarter+2026+Results/26803582.html Thu, 23 Jul 2026 06:00:00 -0400 A.13029261 O.00001036 O.03056012 WST http://www.streetinsider.com/PRNewswire/West+Reports+Second-Quarter+2026+Results/26803582.html <div class="xn-content"> <p class="prntac"><i>Raising Full-Year <person>Net Sales</person> and EPS guidance</i></p><p><span class="legendSpanClass"><location value="LU/us.pa.exton" idsrc="xmltag.org" >EXTON, Pa.</location></span>, <span class="legendSpanClass"><chron>July 23, 2026</chron></span> /PRNewswire/ -- <span value="NYSE:WST" idsrc="xmltag.org" >West Pharmaceutical Services, Inc.</span> (NYSE: WST), a leading provider of innovative, high-quality injectable solutions and services, today announced its financial results for the second quarter of 2026.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> <img src="https://mmx.prnewswire.com/media/MS513349/west-pharma-large-Logo.jpg?id=OA2780622" title="" alt="" /> http://www.streetinsider.com/PRNewswire/West+Reports+Second-Quarter+2026+Results/26803582.html Thu, 23 Jul 2026 06:00:00 -0400 A.13029261 O.00001036 O.03056012 WST http://www.streetinsider.com/PRNewswire/West+Reports+Second-Quarter+2026+Results/26803582.html <div class="xn-content"> <p class="prntac"><i>Raising Full-Year <person>Net Sales</person> and EPS guidance</i></p><p><span class="legendSpanClass"><location value="LU/us.pa.exton" idsrc="xmltag.org" >EXTON, Pa.</location></span>, <span class="legendSpanClass"><chron>July 23, 2026</chron></span> /PRNewswire/ -- <span value="NYSE:WST" idsrc="xmltag.org" >West Pharmaceutical Services, Inc.</span> (NYSE: WST), a leading provider of innovative, high-quality injectable solutions and services, today announced its financial results for the second quarter of 2026.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> <img src="https://mmx.prnewswire.com/media/MS513349/west-pharma-large-Logo.jpg?id=OA2780622" title="" alt="" /> http://www.streetinsider.com/PRNewswire/West+Reports+Second-Quarter+2026+Results/26803582.html Thu, 23 Jul 2026 06:00:00 -0400 A.13029261 O.00001036 O.03056012 WST http://www.streetinsider.com/PRNewswire/West+Reports+Second-Quarter+2026+Results/26803582.html <div class="xn-content"> <p class="prntac"><i>Raising Full-Year <person>Net Sales</person> and EPS guidance</i></p><p><span class="legendSpanClass"><location value="LU/us.pa.exton" idsrc="xmltag.org" >EXTON, Pa.</location></span>, <span class="legendSpanClass"><chron>July 23, 2026</chron></span> /PRNewswire/ -- <span value="NYSE:WST" idsrc="xmltag.org" >West Pharmaceutical Services, Inc.</span> (NYSE: WST), a leading provider of innovative, high-quality injectable solutions and services, today announced its financial results for the second quarter of 2026.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> <img src="https://mmx.prnewswire.com/media/MS513349/west-pharma-large-Logo.jpg?id=OA2780622" title="" alt="" /> http://www.streetinsider.com/PRNewswire/West+Reports+Second-Quarter+2026+Results/26803582.html Thu, 23 Jul 2026 06:00:00 -0400 A.13029261 O.00001036 O.03056012 WST http://www.streetinsider.com/Dividends/West+Pharma+%28WST%29+Declares+%240.22+Quarterly+Dividend%3B+0.2%25+Yield/26795453.html <p>West Pharma (NYSE: WST) declared a quarterly dividend of $0.22 per share, or $0.88 annualized.</p><p>The dividend will be payable on August 5, 2026, to stockholders of record on July 29, 2026, with an ex-dividend date of July 28, 2026.</p><p>The annual yield on the dividend is 0.2 percent.</p><p>For a dividend history and other dividend-related data on West Pharma (WST) <a href="http://www.streetinsider.com/dividend_history.php?q=WST">click here</a>.</p> http://www.streetinsider.com/Dividends/West+Pharma+%28WST%29+Declares+%240.22+Quarterly+Dividend%3B+0.2%25+Yield/26795453.html Tue, 21 Jul 2026 16:00:42 -0400 WST http://www.streetinsider.com/Press+Releases/West+Declares+Quarterly+Dividend/26795440.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.pa.exton" idsrc="xmltag.org" >EXTON, Pa.</location></span>, <span class="legendSpanClass"><chron>July 21, 2026</chron></span> /PRNewswire/ -- On July 21, 2026, the Board of Directors of <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4736099-1&amp;h=1772052968&amp;u=https%3A%2F%2Fedge.prnewswire.com%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4576368-1%26h%3D2393518576%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D4367175-1%2526h%253D1981022109%2526u%253Dhttps%25253A%25252F%25252Fwww.westpharma.com%25252F%2526a%253DWest%252BPharmaceutical%252BServices%25252C%252BInc.%26a%3DWest%2BPharmaceutical%2BServices%252C%2BInc.&amp;a=West+Pharmaceutical+Services%2C+Inc." target="_blank" rel="nofollow"><span value="NYSE:WST" idsrc="xmltag.org" >West Pharmaceutical Services, Inc.</span></a> (NYSE: WST), a global leader in innovative solutions for injectable drug administration, declared its regular quarterly dividend of $0.22 per share on the Company's common stock. The dividend is payable on August 5, 2026 to shareholders of record on July 29, 2026.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/West+Declares+Quarterly+Dividend/26795440.html Tue, 21 Jul 2026 16:00:00 -0400 O.00001036 WST http://www.streetinsider.com/Press+Releases/West+Declares+Quarterly+Dividend/26795440.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.pa.exton" idsrc="xmltag.org" >EXTON, Pa.</location></span>, <span class="legendSpanClass"><chron>July 21, 2026</chron></span> /PRNewswire/ -- On July 21, 2026, the Board of Directors of <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4736099-1&amp;h=1772052968&amp;u=https%3A%2F%2Fedge.prnewswire.com%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4576368-1%26h%3D2393518576%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D4367175-1%2526h%253D1981022109%2526u%253Dhttps%25253A%25252F%25252Fwww.westpharma.com%25252F%2526a%253DWest%252BPharmaceutical%252BServices%25252C%252BInc.%26a%3DWest%2BPharmaceutical%2BServices%252C%2BInc.&amp;a=West+Pharmaceutical+Services%2C+Inc." target="_blank" rel="nofollow"><span value="NYSE:WST" idsrc="xmltag.org" >West Pharmaceutical Services, Inc.</span></a> (NYSE: WST), a global leader in innovative solutions for injectable drug administration, declared its regular quarterly dividend of $0.22 per share on the Company's common stock. The dividend is payable on August 5, 2026 to shareholders of record on July 29, 2026.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/West+Declares+Quarterly+Dividend/26795440.html Tue, 21 Jul 2026 16:00:00 -0400 O.00001036 WST http://www.streetinsider.com/PRNewswire/West+Declares+Quarterly+Dividend/26795440.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.pa.exton" idsrc="xmltag.org" >EXTON, Pa.</location></span>, <span class="legendSpanClass"><chron>July 21, 2026</chron></span> /PRNewswire/ -- On July 21, 2026, the Board of Directors of <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4736099-1&amp;h=1772052968&amp;u=https%3A%2F%2Fedge.prnewswire.com%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4576368-1%26h%3D2393518576%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D4367175-1%2526h%253D1981022109%2526u%253Dhttps%25253A%25252F%25252Fwww.westpharma.com%25252F%2526a%253DWest%252BPharmaceutical%252BServices%25252C%252BInc.%26a%3DWest%2BPharmaceutical%2BServices%252C%2BInc.&amp;a=West+Pharmaceutical+Services%2C+Inc." target="_blank" rel="nofollow"><span value="NYSE:WST" idsrc="xmltag.org" >West Pharmaceutical Services, Inc.</span></a> (NYSE: WST), a global leader in innovative solutions for injectable drug administration, declared its regular quarterly dividend of $0.22 per share on the Company's common stock. The dividend is payable on August 5, 2026 to shareholders of record on July 29, 2026.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/West+Declares+Quarterly+Dividend/26795440.html Tue, 21 Jul 2026 16:00:00 -0400 O.00001036 WST http://www.streetinsider.com/PRNewswire/West+Declares+Quarterly+Dividend/26795440.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.pa.exton" idsrc="xmltag.org" >EXTON, Pa.</location></span>, <span class="legendSpanClass"><chron>July 21, 2026</chron></span> /PRNewswire/ -- On July 21, 2026, the Board of Directors of <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4736099-1&amp;h=1772052968&amp;u=https%3A%2F%2Fedge.prnewswire.com%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4576368-1%26h%3D2393518576%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D4367175-1%2526h%253D1981022109%2526u%253Dhttps%25253A%25252F%25252Fwww.westpharma.com%25252F%2526a%253DWest%252BPharmaceutical%252BServices%25252C%252BInc.%26a%3DWest%2BPharmaceutical%2BServices%252C%2BInc.&amp;a=West+Pharmaceutical+Services%2C+Inc." target="_blank" rel="nofollow"><span value="NYSE:WST" idsrc="xmltag.org" >West Pharmaceutical Services, Inc.</span></a> (NYSE: WST), a global leader in innovative solutions for injectable drug administration, declared its regular quarterly dividend of $0.22 per share on the Company's common stock. The dividend is payable on August 5, 2026 to shareholders of record on July 29, 2026.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/West+Declares+Quarterly+Dividend/26795440.html Tue, 21 Jul 2026 16:00:00 -0400 O.00001036 WST http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++WEST+PHARMACEUTICAL+SERV++For%3A+Jul+14/26768575.html si-local-file:///var/storage/secattach/20260714/26768575.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++WEST+PHARMACEUTICAL+SERV++For%3A+Jul+14/26768575.html Tue, 14 Jul 2026 16:29:00 -0400 O.00001036 WST http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++WEST+PHARMACEUTICAL+SERV++For%3A+Jul+14/26768575.html si-local-file:///var/storage/secattach/20260714/26768575.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++WEST+PHARMACEUTICAL+SERV++For%3A+Jul+14/26768575.html Tue, 14 Jul 2026 16:29:00 -0400 O.00001036 WST http://www.streetinsider.com/New+Coverage/BNP+Paribas+Exane+Starts+West+Pharmaceutical+%28WST%29+at+Outperform/26759740.html <p>BNP Paribas Exane initiates coverage on West Pharmaceutical (NYSE: WST) with a Outperform rating and a price target of $447.00.</p><p>For an analyst ratings summary and ratings history on West Pharmaceutical <a href="http://www.streetinsider.com/rating_history.php?q=WST">click here</a>. For more ratings news on West Pharmaceutical <a href="http://www.streetinsider.com/stock_lookup_news.php?q=WST&amp;type=analyst">click here</a>.</p><p>Shares of West Pharmaceutical closed at $353.71 yesterday.</p> http://www.streetinsider.com/New+Coverage/BNP+Paribas+Exane+Starts+West+Pharmaceutical+%28WST%29+at+Outperform/26759740.html Mon, 13 Jul 2026 07:21:54 -0400 WST http://www.streetinsider.com/Analyst+PT+Change/West+Pharmaceutical+%28WST%29+PT+Raised+to+%24365+at+Morgan+Stanley/26750586.html Morgan Stanley analyst Kallum Titchmarsh raised the price target on West Pharmaceutical (NYSE: WST) to $365.00 (from $325.00) while maintaining a Equalweight rating. http://www.streetinsider.com/Analyst+PT+Change/West+Pharmaceutical+%28WST%29+PT+Raised+to+%24365+at+Morgan+Stanley/26750586.html Thu, 09 Jul 2026 08:16:42 -0400 WST http://www.streetinsider.com/Press+Releases/West+to+Host+Second-Quarter+2026+Conference+Call/26738471.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.pa.exton" idsrc="xmltag.org" >EXTON, Pa.</location></span>, <span class="legendSpanClass"><chron>July 7, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4726130-1&amp;h=3338706994&amp;u=https%3A%2F%2Fwww.westpharma.com%2F&amp;a=West+Pharmaceutical+Services%2C+Inc." target="_blank" rel="nofollow"><span value="NYSE:WST" idsrc="xmltag.org" >West Pharmaceutical Services, Inc.</span></a> (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release second-quarter 2026 financial results before the market opens on Thursday, July 23, 2026, and will follow with a conference call to discuss the results and business expectations at 8:00 a.m. Eastern Time.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/West+to+Host+Second-Quarter+2026+Conference+Call/26738471.html Tue, 07 Jul 2026 06:00:00 -0400 O.00001036 WST